Maryland is Anything But Crabby over $1.7 billion in Pharmaceutical-Biotech Capital Investment
Maryland is Anything But Crabby over $1.7 billion in Pharmaceutical-Biotech Capital Investment
East Baltimore is about to get a facelift when the $450 million first phase of the planned Life Science and Tech Center begins construction later this spring.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Mexico Registers US$2 Billion in Pharmaceutical Investments
- New England Sees $27 Billion in Projects Under Construction
- Pharma, Manufacturing Lead Indiana to $21.6 Billion of Projects Under Const...
- India Aims to Reduce Dependence on China for Pharma Market
- BMS Investing $400 Million in Dublin Sterile Drug Expansion